ArticleHuman reproduction open2026
Heterogeneity in semen-mediated tolerogenic responses: defining immunological determinants of reproductive compatibility.
Article in Human reproduction open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
study questionDo particular pairs of individuals modeling sexual pairs exhibit differences in the induction of semen-mediated long-lasting tolerance in support of pregnancy? SUMMARY ANSWER: Yes, factors from both sexes contribute to the variability in the induction of long-lived regulatory T cells (Tregs) in response to semen, with factors related to the recipient seeming to slightly outweigh the factors related to the semen donor. WHAT IS KNOWN ALREADY: Semen contains multiple immunomodulatory factors that can influence reproductive tract immunity in the recipient, promote tolerance to antigens from the semen donor (designated henceforth as 'paternal'), and ultimately support successful pregnancy. These factors include the soluble fraction containing prostaglandins and cytokines, as well as a very high concentration of extracellular vesicles (EVs). Both soluble and vesicular fractions of semen have been shown to promote tolerogenic phenotypes and migration in antigen-presenting cells (APCs), and to induce Tregs. This study was undertaken to understand the variation in tolerance induction between pairs of individuals modeling sexually active couples. STUDY DESIGN SIZE DURATION: We designed an PARTICIPANTS/MATERIALS SETTING
methodsThis study used an MAIN RESULTS AND THE ROLE OF CHANCE: HLA-G content in semen (SEV and VDSP) varied markedly across donors, ranging from undetectable to high concentrations. Similarly, semen's capacity to generate adenosine from ATP differed by ∼4-fold among donors. Induction of Tregs by SEV and VDSP from 11 semen donors was highly variable, from 2.8% to 63.4% of CD4+ T cell population. Semen fractions from a few donors consistently elicited lower tolerogenic responses across all recipients. However, when we considered the combined effects of both semen fractions, none of the semen donors failed to elicit a measurable tolerogenic response. On the other hand, one recipient was a consistently low responder to tolerance induction. Thus, both recipient immune cells' features and semen-intrinsic properties are significant determinants of tolerogenic responsiveness. Semen re-exposure enhanced Treg AIM expression. The strongest effect was observed when Tregs were exposed to VDSP-loaded MoDCs. In contrast, SEV-loaded MoDCs caused a much weaker response. LARGE SCALE DATA: N/A. LIMITATIONS REASONS FOR CAUTION: One limitation of our study is that we used semen and circulating recipient cells from random donors not selected for any clinical characteristics, such as history of infertility. In addition, we did not correlate HLA-G content and adenosine-generating enzyme expression levels with the Treg and AIM readouts. We show, via Treg activation, that semen induces tolerance to its antigens, but we do not demonstrate which specific antigens are recognized. We posit that the variation in semen-induced tolerance observed between couples plays a role in reproductive outcomes; however, larger studies in clinically characterized cohorts and using cells from the tissue microenvironment will be required to establish this link. WIDER IMPLICATIONS OF THE
findingsOur findings demonstrate that semen-induced tolerance is highly variable and may be more strongly shaped by recipient factors than by semen donor factors. In addition, the generation of Tregs with enhanced activation to previously encountered semen supports the concepts of trained immunity and antigen-specific tolerance that arise cumulatively following exposure to semen from the partner. These Tregs are poised to expand and support pregnancies with fetuses expressing paternal alloantigens.
fundingThis work was supported by the following grants: National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01AI153342) to L.V., National Institutes of Health/National Institute on Drug Abuse (R01DA040386) to F.H., National Institutes of Health/National Center for Advancing Translational Sciences (KL2TR002317) to G.G.G. DISCLOSURES: The authors have no conflicts of interest to declare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.